hCD47/hSIRPA(2)
品系全名
C57BL/6JSmo-Sirpatm2(hSIRPA)Cd47tm1(hCD47)Smoc
目录号
NM-HU-2000111
品系状态
胚胎冻存
品系描述
验证数据
Fig 1. Detection of m&hCD47 expression on T, B, NK cells in HO hSIRPA(2)/hCD47 mice.
Fig 2. Detection of m&hCD47 expression on erythrocytes and platelets in HO hSIRPA(2)/hCD47 mice.
Fig 3. Detection of m&hCD47 expression in PB sample in HO hSIRPA(2)/hCD47 mice.
Fig 4. Detection of m&hCD47 expression in spleen sample in HO hSIRPA(2)/hCD47 mice.
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
